Table 6. Number of significantly detected viral variants throughout the study period for each patient.
| Patient | Sample 1 | Sample 2 | Sample 3 | Sample 4 | Sample 5 | Sample 6 | Sample 7 | Sample 8 |
| 1 | 57 a | 17 b | 38 | 33 | 17c | 30 | - | - |
| 2 | 72 | 23 | 44 | 32 | 22 | 21 | - | - |
| 3 | 59 | 76 | 30 | 30 | 25 | 49 | - | - |
| 4 | 73 | 76 | 70 | 43 | 35 | 43 | 21 | 32 |
| 5 | 65 | 53 | 40 | 44 | 24 | 46 | - | - |
| 6 | 63 | 42 | 38 | 31 | 35 | 44 | 54 | 31 |
Footnotes
aVariants in italic are sampled before any treatment is initiated.
Variants in bold are sampled during treatment failure.
Variants in normal text are sampled during treatment interruption.